# Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients

> **NCT05695261** · PHASE2 · RECRUITING · sponsor: **Rima Rachid** · enrollment: 37 (estimated)

## Conditions studied

- Allergy, Peanut
- Peanut Allergy
- Peanut Hypersensitivity
- Peanut-Induced Anaphylaxis
- Food Allergy
- Food Allergy Peanut

## Interventions

- **BIOLOGICAL:** Microbial Transplantation Therapy
- **DRUG:** Antibiotic
- **OTHER:** Placebo (in place of MTT)
- **OTHER:** Placebo (in place of antibiotics)
- **OTHER:** Oral Immunotherapy (OIT)

## Key facts

- **NCT ID:** NCT05695261
- **Lead sponsor:** Rima Rachid
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-08
- **Primary completion:** 2027-01-11
- **Final completion:** 2027-03-01
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05695261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05695261, "Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05695261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*